“Drugs don’t work in people who don’t take them.” The same can be said for preventative care. If the messages we use to persuade people to engage in preventative healthcare activities go in one ear and out the other, our clinics go empty and our medical institutions, instead, are forced to engage patients when it’s too late. For high-risk or impoverished populations that rely on medicare, this approach to care can be especially risky —and costly. At Think 2018, IBM’s premier conference of the year, Mind Genomics Advisors and University of Pennsylvania’s Perelman School of Medicine will be presenting on the power of machine learning to more effectively engage at-risk populations with personalized messaging devised from rapid empirical testing. Specifically, we will explore how the Viewpoint Identifier was deployed to better understand the unique motivators of low-income African American men to pursue colonoscopies, thereby improving early detection rates.
IBM Think 2018 runs from March 19-22 in Las Vegas, NV. This interactive event explores cloud computing and AI, going beyond presentations and networking to including thousands of hands-on labs, soft skills workshops, hundreds of certification opportunities, stand out entertainment and much more. IBM Senior Leaders and industry luminaries including Lisa Ling, Dr. Michia Kaku, Dr. Neil degrasse Tyson, Gary Reedy, Wade Davis will speak to the next frontier of innovative technologies. Dr. Ken Rotondo, president and founding partner of Mind Genomics Advisors, and Dr. Akin Oyalowo of the University of Pennsylvania will be presenting on March 20 in Session 8578.
To learn more about IBM Think 2018 or register to live-stream the conference, click here https://www.ibm.com/events/think/register/